Skip to content

Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions

Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04219605
Enrollment
226
Registered
2020-01-07
Start date
2020-12-01
Completion date
2023-03-30
Last updated
2025-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophic Vaginitis, Bacterial Vaginosis, Candida Albicans Vulvovaginitis, Candida Vulvovaginitis, Desquamative Inflammatory Vaginitis, Trichomonas Vaginitis

Brief summary

Evaluate the diagnostic performance of the Gyni™ device to detect different vaginitis conditions by comparison to microscopic diagnosis and related lab tests.

Detailed description

During gynecological exams, vaginal discharge samples will be are taken for testing the pH level, microscopic examination and laboratory examinations (vaginal cultures and sexually transmitted infections). One additional sample will be taken intended for the Gyni™ system diagnosis. This additional examination will be performed in the clinic by pulling the cytobrush through a dedicated cartridge and scanning it in the Gyni table-top scanner. The result diagnosis will be anonymously kept in the cloud. The diagnosis suggested by the Gyni system will not be visible to the physician in order to prevent any bias. Results from the physician, from the device and from the lab will be summarized and compared by the chief investigator

Interventions

None listed

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women with vaginal complaints: Discharge, Malodor, Itching, Irritation, Dyspareunia, Pain * Age \>= 18y

Exclusion criteria

* Age \< 18y * Not eligible to sign an informed consent * Vaginal discharge samples found microscopically not interpret-able by the investigator due to patient using vaginal creams, ointments, lubricants or sperm presence. * During menstruation

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic performance12 monthsSpecificity and sensitivity of the device performance in regard to vaginitis conditions

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026